Does Mandatory Opioid Prescriber Education Go Far Enough? Congress Might Say No

Congress and FDA already are sparring over the drug companies’ mandate to pay for the prescriber education included in the national prescription drug abuse plan.

More from Archive

More from Pink Sheet